The activation of SIRT1 can inhibit the malignant behavior of renal cell carcinoma cells by restoring the activity of AMPK and inducing cell apoptosis, thereby weakening the invasiveness and migration ability of tumor cells (61). This evidence concerns the gene SIRT1 and hereditary clear cell renal cell carcinoma.